BETV4

Polcalcin Bet v 4 Recombinant
Shipped with Ice Packs
In Stock

Description

Overview of BETV4

BETV4 belongs to the polcalcin superfamily, characterized by its ability to bind calcium ions and mediate allergic reactions. It is a recombinant protein produced in either insect cells (SF9) or E. coli, with applications in allergy diagnostics and immunological studies .

PropertyValue/DescriptionSource
Molecular Weight~10.3–10.4 kDa (recombinant)
Source OrganismBetula pendula (mature pollen)
Recombinant ProductionSF9 insect cells or E. coli
Tags6xHis tag (N-terminal)

Comparison of Recombinant BETV4 Preparations

ParameterSF9 (Prospec Bio)E. coli (Sino Biological)
Purity>80%>95%
Formulation20 mM HEPES, 6M ureaNot specified
Storage-20°C-20°C to -80°C
ApplicationsImmunodot tests, IgE bindingResearch use, allergy diagnostics

Immunological Functions

BETV4’s primary role lies in its interaction with the human immune system:

  1. IgE Binding: Acts as a ligand for IgE antibodies, enabling diagnostic assays to identify allergen-specific responses .

  2. Cross-Reactivity: Serves as a marker for plant polysensitization, where IgE antibodies react with homologous proteins across plant species .

  3. Immunodot Testing: Used in serum panels to differentiate between true sensitization and cross-reactivity in allergy diagnostics .

Applications in Research

BETV4 is employed in:

  • Allergy Diagnostics: Validates IgE-specific responses in patient sera.

  • Polcalcin Studies: Investigates calcium-dependent allergenicity and cross-reactivity mechanisms.

  • Therapeutic Development: Serves as a model for desensitization strategies in allergy immunotherapy.

Key Research Findings

  • Allergenic Activity: Demonstrated IgE binding in immunodot assays with positive sera panels .

  • Stability: Retains functionality in formulations containing urea, enabling long-term storage .

  • Purity Impact: Higher purity (>95%) in E. coli-produced BETV4 may enhance assay reliability compared to SF9-derived preparations .

Product Specs

Introduction
BETV4, primarily found in mature birch (Betula verrucosa) pollen, is a known human allergen. As a 2-EF-hand type calcium-binding protein, BETV4 is present in pollen across various plant species. Its cross-reactivity makes it a potential marker allergen for identifying plant polysensitization.
Description
Recombinant BETV4, produced in SF9 insect cells, is a glycosylated polypeptide chain with a calculated molecular mass of 10,473 Daltons. It is expressed with an N-terminal 6xHis tag and purified using proprietary chromatographic techniques.
Physical Appearance
Clear, sterile-filtered solution.
Formulation
BETV4 is supplied in a buffer solution of 20mM HEPES at pH 7.9 and 6M Urea.
Stability
For short-term storage (2-4 weeks), keep at 4°C. For long-term storage, freeze at -20°C. Repeated freezing and thawing should be avoided.
Purity
Purity exceeds 80%, as determined by SDS-PAGE analysis.
Immunological Functions
This protein exhibits the following immunological functions: binding to human IgE antibodies and demonstrating reactivity in immunodot assays with positive and negative serum panels.
Synonyms

Polcalcin Bet v 4, Calcium-binding pollen allergen Bet v 4, Bet v 4, BETV4.

Source
Sf9 insect cells.

Q&A

What is BETV4 and what are its primary biological functions?

BETV4 is a calcium-binding protein of 2-EF-hand type primarily expressed in mature birch (Betula verrucosa) pollen. It functions as an allergen, causing allergic reactions in humans, and exists in pollen of various plant species. Due to its cross-reactivity, BETV4 serves as a marker allergen for plant polysensitization .

It's important to note that literature contains some inconsistency regarding BETV4's identity. While some sources describe it as a pollen allergen , others characterize it as a member of the BET (bromodomain and extra-terminal) family of proteins involved in gene regulation and transcriptional control . This FAQ focuses primarily on BETV4 as the pollen allergen.

How is recombinant BETV4 produced for research applications?

Recombinant BETV4 for research is typically produced in Sf9 insect cells as a glycosylated polypeptide chain with a calculated molecular mass of 10,473 Dalton. The protein is expressed with a 6xHis tag at the N-terminus to facilitate purification through proprietary chromatographic techniques. The final product is supplied as a sterile filtered clear solution in 20mM HEPES buffer (pH 7.9) containing 6M Urea .

What storage and stability considerations are critical for BETV4 experiments?

For optimal experimental results, researchers should follow these stability guidelines:

Storage PeriodRecommended TemperatureNotes
Short-term (2-4 weeks)4°CIf entire vial will be used within this period
Long-term-20°CFor extended storage periods
Multiple useVariesAvoid multiple freeze-thaw cycles

Proper storage conditions are critical to maintaining the protein's immunological functions, including its ability to bind IgE-type human antibodies .

What analytical techniques provide the most reliable detection of BETV4 in experimental systems?

Several analytical techniques have been validated for BETV4 research:

TechniqueApplicationRecommended ParametersResearch Considerations
Western BlottingProtein detectionAntibody dilution: 1:500-1:5000Useful for analyzing expression in complex samples
ELISAQuantitative analysisAntibody dilution: 1:2000-1:10000Provides sensitive quantification of BETV4 levels
Immunodot TestQualitative detectionUsing positive/negative sera panelsEfficient for screening multiple samples

When using antibody-based detection, the BETV4 polyclonal antibody (PACO50214) has been validated for Western blotting and ELISA applications. This antibody is raised against recombinant Betula pendula Polcalcin Bet v 4 protein (amino acids 1-85) and purified using Protein G to >95% purity .

How can researchers optimize experimental design when studying BETV4's role in allergic responses?

While specific experimental designs for BETV4 aren't explicitly described in the literature, researchers can apply Bayesian optimal experimental design principles to maximize information gained from BETV4 studies. These approaches include:

  • Implementing search algorithms from artificial intelligence that efficiently explore possible design parameters

  • Utilizing sampling procedures to evaluate design parameter combinations more efficiently

  • Collecting data across different experimental designs to compare their ability to discriminate among competing models of BETV4 function

These computational improvements make experimental procedures more tractable and can significantly reduce the amount of data required to distinguish between behavioral models of allergic responses to BETV4.

What are the primary methodological challenges in transcriptomic analysis of BETV4 expression?

Transcriptomic analysis of BETV4 expression requires careful consideration of several methodological challenges:

  • Sequence processing and assembly can be performed using tools like 454 Newbler with default parameters (40 bp overlap and 90% identity)

  • Translation frame assessment should be conducted through BLASTx searches against relevant databases

  • Proper annotation requires tools such as InterProScan and Gene Ontology terms

  • To identify differential gene expression between samples, contigs should be clustered using applications like CD-Hit 454 (90% similarity) to eliminate redundant sequences

  • Statistical analysis must employ appropriate normalization methods and linear regression models based on Gaussian distribution

Researchers should ensure they include only contigs with a minimum threshold of mapped reads (e.g., eight or more) and apply appropriate false discovery rate controls.

How does BETV4 contribute to cross-reactivity patterns in allergy diagnostics?

BETV4's calcium-binding structure makes it an important marker for cross-reactivity studies. As a polcalcin present in various plant pollens, it can help identify patients with polysensitization patterns. When designing cross-reactivity studies, researchers should:

  • Incorporate BETV4 in multiplex testing panels alongside other calcium-binding pollen allergens

  • Apply cluster analysis to identify patterns of sensitization across patient populations

  • Consider BETV4 as a potential marker when investigating patients with multiple plant allergies

Understanding these cross-reactivity patterns has significant implications for both diagnosis and immunotherapy approaches.

What role does BETV4 play in atopic dermatitis research?

Cluster analysis of molecular components in patients with atopic dermatitis has shown that sensitization to molecular allergens is a significant factor. While specific percentages for BETV4 sensitization aren't provided in the available research, studies indicate that sensitization to molecular fungal allergens was recorded in 58% of atopic dermatitis patients .

Researchers investigating BETV4's role in atopic dermatitis should consider:

  • Using ISAC Multiplex testing to simultaneously assess sensitization to multiple allergens including BETV4

  • Applying cluster analysis to identify patterns of sensitization

  • Correlating BETV4 sensitization with clinical manifestations of atopic dermatitis

How can immunological assays for BETV4 be validated for research applications?

Validation of immunological assays for BETV4 should include:

  • Confirmation of binding to IgE-type human antibodies

  • Verification through immunodot tests with both positive and negative sera panels

  • Assessment of specificity through cross-reactivity testing with related allergens

  • Evaluation of sensitivity using standardized allergen preparations

Researchers should document purification methods, storage conditions, and quality control metrics when reporting results from BETV4 immunological assays.

How does the molecular structure of BETV4 relate to its allergenicity?

BETV4 is a calcium-binding protein featuring a 2-EF-hand structural motif. The EF-hand domains consist of helix-loop-helix structures that bind calcium ions. These structural features are critical to understanding BETV4's:

  • Ability to bind calcium ions, which may affect protein conformation

  • Interaction with IgE antibodies from allergic patients

  • Cross-reactivity with similar calcium-binding proteins from other plant species

  • Stability under different experimental conditions

Structural studies of BETV4 are essential for developing targeted therapeutic approaches for birch pollen allergies.

What approaches can be used to compare BETV4 across different plant species?

To conduct comparative studies of BETV4 across plant species, researchers should consider:

  • Sequence alignment analysis to identify conserved domains and variable regions

  • Recombinant expression of BETV4 homologs from different species for functional comparison

  • Structural analysis of calcium-binding domains across species

  • Immunological cross-reactivity testing using patient sera

  • Transcriptomic profiling to compare expression patterns in different plant species and tissues

These comparative approaches can help identify conserved allergenicity determinants and species-specific variations that might affect diagnosis and treatment.

What considerations are important when designing antibodies for BETV4 research?

When designing antibodies for BETV4 research, several factors are critical:

ConsiderationDetailsResearch Implications
Immunogen SelectionRecombinant Betula pendula Polcalcin Bet v 4 protein (1-85AA)Ensures specificity to the target protein
Host SpeciesRabbit (for polyclonal antibodies)Affects downstream application compatibility
Purification MethodProtein G purification (>95% purity)Influences specificity and background signal
Storage Buffer0.03% Proclin 300, 50% Glycerol, 0.01M PBS, pH 7.4Critical for antibody stability and performance
Validated ApplicationsELISA (1:2000-1:10000), WB (1:500-1:5000)Determines research application suitability

Researchers should validate antibody performance in their specific experimental systems before proceeding with large-scale studies .

How might optimal experimental design improve BETV4 allergy research?

Applying optimal experimental design principles to BETV4 research offers several advantages:

  • More efficient exploration of experimental design parameters through AI-based search algorithms

  • Reduced data requirements for model discrimination through Bayesian optimization approaches

  • Improved ability to dynamically optimize online experiments

  • Enhanced capability to test competing hypotheses about BETV4's role in allergic responses

What transcriptomic approaches show promise for understanding BETV4 expression?

Advanced transcriptomic approaches that could enhance BETV4 expression research include:

  • Deep sequencing with proper removal of ribosomal, mitochondrial, and chloroplast reads

  • Assembly of sequences using tools like 454 Newbler 2.6 with appropriate overlap and identity parameters

  • Translation frame assessment using BLASTx searches against Swiss-Prot

  • Annotation with InterProScan and Gene Ontology terms

  • Differential expression analysis using normalized read counts and appropriate statistical models

These methodologies can provide deeper insights into the regulation of BETV4 expression across different plant tissues and environmental conditions.

How might BETV4 research inform broader allergen immunotherapy approaches?

Understanding BETV4's molecular characteristics and cross-reactivity patterns has important implications for allergen immunotherapy:

  • Its role as a marker allergen for plant polysensitization could help identify patients who might benefit from specific immunotherapy approaches

  • Structural studies could inform the design of hypoallergenic variants for safer immunotherapy

  • Cross-reactivity patterns might explain clinical responses to immunotherapy targeting related allergens

  • Comparative studies across plant species could help develop broader-spectrum immunotherapy approaches

Research in this area requires careful integration of molecular, immunological, and clinical data to translate findings into improved patient care.

Product Science Overview

Structure and Function

Polcalcin Bet v 4 is a protein with a molecular weight of approximately 9.3 kDa . It contains two EF-hand motifs, which are helix-loop-helix structural domains capable of binding calcium ions. This calcium-binding property is crucial for the protein’s stability and function.

Allergenic Properties

Bet v 4 is considered a minor allergen because it is recognized by the immune system of a smaller percentage of individuals allergic to birch pollen. Studies have shown that about 20% of patients allergic to birch pollen have specific IgE antibodies against Bet v 4 . Despite being a minor allergen, Bet v 4 plays a significant role in the diagnosis and management of birch pollen allergies.

Recombinant Bet v 4

Recombinant Bet v 4 is produced using genetic engineering techniques. The gene encoding Bet v 4 is cloned and expressed in a suitable host organism, such as Escherichia coli . The recombinant protein is then purified, often using immobilized metal affinity chromatography, to achieve high purity levels suitable for research and diagnostic applications .

Applications

Recombinant Bet v 4 is primarily used in allergen-specific IgE antibody testing. It helps in the diagnosis of birch pollen allergies and can be used to identify individuals who are polysensitized to multiple pollen allergens . The recombinant form of Bet v 4 is also valuable in research studies aimed at understanding the molecular mechanisms of allergic reactions and developing new therapeutic approaches.

Epidemiology

The prevalence of sensitization to Bet v 4 varies geographically. For instance, studies have reported that 5% of individuals in Finland, 8% in Sweden, 11% in Austria, 6% in France, 27% in Italy, and 7% in Switzerland have specific IgE antibodies against Bet v 4 . In Japan, only 2.5% of birch-allergic individuals were found to have IgE antibodies against Bet v 4 .

Cross-Reactivity

Polcalcin Bet v 4 is known to be highly cross-reactive with other polcalcins found in different pollen species. This cross-reactivity can lead to polysensitization, where individuals are allergic to multiple pollen types. For example, polcalcins from timothy grass (Phl p 7) and alder (Aln g 4) can also trigger allergic reactions in individuals sensitized to Bet v 4 .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.